دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Middelburg and Shuni Viruses in South Africa—Potential Human Pathogens
doi : 10.1093/cid/ciac192
Clinical Infectious Diseases, Volume 74, Issue 10, 15 May 2022, Pages i–ii
Factors Associated With Readmission in the United States Following Hospitalization With Coronavirus Disease 2019
Elizabeth C Verna, Charles Landis, Robert S Brown, Jr, Andrea R Mospan, Julie M Crawford, Janet S Hildebrand, Heather L Morris, Breda Munoz, Michael W Fried, K Rajender Reddy
doi : 10.1093/cid/ciab464
Clinical Infectious Diseases, Volume 74, Issue 10, 15 May 2022, Pages 1713–1721
Patients hospitalized for coronavirus disease 2019 (COVID-19) may experience complications following hospitalization and require readmission. In this analysis, we estimated the rate and risk factors associated with COVID-19–related readmission and inpatient mortality.
Viral Load of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Respiratory Aerosols Emitted by Patients With Coronavirus Disease 2019 (COVID-19) While Breathing, Talking, and Singing
Kristen K Coleman, Douglas Jie Wen Tay, Kai Sen Tan, Sean Wei Xiang Ong, The Son Than, Ming Hui Koh, Yi Qing Chin, Haziq Nasir, Tze Minn Mak, Justin Jang Hann Chu, Donald K Milton, Vincent T K Chow, Paul Anantharajah Tambyah, Mark Chen, Kwok Wai Tham
doi : 10.1093/cid/ciab691
Clinical Infectious Diseases, Volume 74, Issue 10, 15 May 2022, Pages 1722–1728
Multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) superspreading events suggest that aerosols play an important role in driving the coronavirus disease 2019 (COVID-19) pandemic. To better understand how airborne SARS-CoV-2 transmission occurs, we sought to determine viral loads within coarse (>5 μm) and fine (≤5 μm) respiratory aerosols produced when breathing, talking, and singing.
Excess Invasive Meningococcal Disease Associated With Seasonal Influenza, South Africa, 2003–2018
Susan Meiring, Stefano Tempia, Emanuel M Dominic, Linda de Gouveia, Jo McAnerney, Anne von Gottberg, Cheryl Cohen
doi : 10.1093/cid/ciab702
Clinical Infectious Diseases, Volume 74, Issue 10, 15 May 2022, Pages 1729–1735
Invasive meningococcal disease (IMD) is a devastating illness with high mortality rates. Like influenza, endemic IMD is seasonal, peaking in winter. Studies suggest that circulation of influenza virus may influence the timing and magnitude of IMD winter peaks.
Proposed Linezolid Dosing Strategies to Minimize Adverse Events for Treatment of Extensively Drug-Resistant Tuberculosis
Marjorie Z Imperial, Jerry R Nedelman, Francesca Conradie, R M Savic
doi : 10.1093/cid/ciab699
Clinical Infectious Diseases, Volume 74, Issue 10, 15 May 2022, Pages 1736–1747
We evaluated Nix-TB trial data (NCT02333799, N = 109) to provide dosing recommendations to potentially minimize linezolid toxicity in patients with extensively drug-resistant tuberculosis. .
The Impact of Coronavirus Disease 2019 (COVID-19) on Healthcare-Associated Infections
Meghan A Baker, Kenneth E Sands, Susan S Huang, Ken Kleinman, Edward J Septimus, Neha Varma, Jackie Blanchard, Russell E Poland, Micaela H Coady, Deborah S Yokoe, Sarah Fraker, Allison Froman, Julia Moody, Laurel Goldin, Amanda Isaacs, Kacie Kleja, Kimberly M Korwek, John Stelling, Adam Clark, Richard Platt, Jonathan B Perlin, CDC Prevention Epicenters Program
doi : 10.1093/cid/ciab688
Clinical Infectious Diseases, Volume 74, Issue 10, 15 May 2022, Pages 1748–1754
The profound changes wrought by coronavirus disease 2019 (COVID-19) on routine hospital operations may have influenced performance on hospital measures, including healthcare-associated infections (HAIs). We aimed to evaluate the association between COVID-19 surges and HAI and cluster rates.
It’s Hard to Measure Success While Caring for Surges in Coronavirus Disease 2019 (COVID-19) Hospitalizations
Lindsey Gottlieb, Scott K Fridkin
doi : 10.1093/cid/ciab740
Clinical Infectious Diseases, Volume 74, Issue 10, 15 May 2022, Pages 1755–1756
Neutrophils Contribute to Severity of Tuberculosis Pathology and Recovery From Lung Damage Pre- and Posttreatment
Caleb Nwongbouwoh Muefong, Olumuyiwa Owolabi, Simon Donkor, Salome Charalambous, Abhishek Bakuli, Andrea Rachow, Christof Geldmacher, Jayne S Sutherland
doi : 10.1093/cid/ciab729
Clinical Infectious Diseases, Volume 74, Issue 10, 15 May 2022, Pages 1757–1766
Despite microbiological cure, about 50% of tuberculosis (TB) patients have poor lung recovery. Neutrophils are associated with lung pathology; however, CD16/CD62L-defined subsets have not been studied in TB. Using flow cytometry, we monitored frequencies, phenotype, and function of neutrophils following stimulation with Mycobacterium tuberculosis (Mtb) whole cell lysate (WCL) and ESAT-6/CFP-10 fusion protein (EC) in relation to lung pathology.
Pharmacokinetics of First-Line Drugs in Children With Tuberculosis, Using World Health Organization–Recommended Weight Band Doses and Formulations
Chishala Chabala, Anna Turkova, Anneke C Hesseling, Kevin M Zimba, Marieke van der Zalm, Monica Kapasa, Megan Palmer, Maxwell Chirehwa, Lubbe Wiesner, Eric Wobudeya, Aarti Kinikar, Vidya Mave, Syed Hissar, Louise Choo, Kristen LeBeau, Veronica Mulenga, Robb Aarnoutse, Diana Gibb, Helen McIlleron
doi : 10.1093/cid/ciab725
Clinical Infectious Diseases, Volume 74, Issue 10, 15 May 2022, Pages 1767–1775
Dispersible pediatric fixed-dose combination (FDC) tablets delivering higher doses of first-line antituberculosis drugs in World Health Organization–recommended weight bands were introduced in 2015. We report the first pharmacokinetic data for these FDC tablets in Zambian and South African children in the treatment-shortening SHINE trial.
Household Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in the United States: Living Density, Viral Load, and Disproportionate Impact on Communities of Color
Carla Cerami, Zachary R Popkin-Hall, Tyler Rapp, Kathleen Tompkins, Haoming Zhang, Meredith S Muller, Christopher Basham, Maureen Whittelsey, Srijana B Chhetri, Judy Smith, Christy Litel, Kelly D Lin, Mehal Churiwal, Salman Khan, Rebecca Rubinstein, Faith Claman, Katie Mollan, David Wohl, Lakshmanane Premkumar, Kimberly A Powers, Jonathan J Juliano, Feng-Chang Lin, Jessica T Lin
doi : 10.1093/cid/ciab701
Clinical Infectious Diseases, Volume 74, Issue 10, 15 May 2022, Pages 1776–1785
Households are hot spots for severe acute respiratory syndrome coronavirus 2 transmission.
Incidence, Clinical Presentation, Relapses and Outcome of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Patients Treated With Anti-CD20 Monoclonal Antibodies
Jorge Calderón-Parra, Elena Múñez-Rubio, Ana Fernández-Cruz, MarÃa Cristina GarcÃa-Sánchez, Esther Maderuelo-González, Marcos López-Dosil, Marina Calvo-Salvador, Isolina Baños-Pérez, Manuel Valle-Falcones, Antonio Ramos-MartÃnez
doi : 10.1093/cid/ciab700
Clinical Infectious Diseases, Volume 74, Issue 10, 15 May 2022, Pages 1786–1794
Our objective is to describe the presentation and complications, including relapses, of coronavirus disease 2019 (COVID-19) in patients under anti-CD20 treatments. In addition, to describe viral clearance and determine the safety of reintroducing anti-CD20 treatment.
Effectiveness of Continuous Endotracheal Cuff Pressure Control for the Prevention of Ventilator-Associated Respiratory Infections: An Open-Label Randomized, Controlled Trial
Vu Quoc Dat, Lam Minh Yen, Huynh Thi Loan, Vu Dinh Phu, Nguyen Thien Binh, Ronald B Geskus, Dong Huu Khanh Trinh, Nguyen Thi Hoang Mai, Nguyen Hoan Phu, Nguyen Phu Huong Lan, Tran Phuong Thuy, Nguyen Vu Trung, Nguyen Trung Cap, Dao Tuyet Trinh, Nguyen Thi Hoa, Nguyen Thi Thu Van, Vy Thi Thu Luan, Tran Thi Quynh Nhu, Hoang Bao Long, Nguyen Thi Thanh Ha, Ninh Thi Thanh Van, James Campbell, Ehsan Ahmadnia, Evelyne Kestelyn, Duncan Wyncoll, Guy E Thwaites, Nguyen Van Hao, Le Thanh Chien, Nguyen Van Kinh, Nguyen Van Vinh Chau, H Rogier van Doorn, C Louise Thwaites, Behzad Nadjm
doi : 10.1093/cid/ciab724
Clinical Infectious Diseases, Volume 74, Issue 10, 15 May 2022, Pages 1795–1803
An endotracheal tube cuff pressure between 20 and 30 cmH2O is recommended to prevent ventilator-associated respiratory infection (VARI). We aimed to evaluate whether continuous cuff pressure control (CPC) was associated with reduced VARI incidence compared with intermittent CPC.
The Incidence of Hepatitis C Among Gay, Bisexual, and Other Men Who Have Sex With Men in Australia, 2009–2019
Brendan L Harney, Rachel Sacks-Davis, Daniela K van Santen, Michael Traeger, Anna L Wilkinson, Jason Asselin, Carol El-Hayek, Christopher K Fairley, Norman Roth, Mark Bloch, Gail Matthews, Basil Donovan, Rebecca Guy, Mark Stoové, Margaret E Hellard, Joseph S Doyle, Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of Sexually Transmissible Infections and Blood-borne Viruses (ACCESS)
doi : 10.1093/cid/ciab720
Clinical Infectious Diseases, Volume 74, Issue 10, 15 May 2022, Pages 1804–1811
Hepatitis C virus (HCV) infection has been reported among gay, bisexual, and other men who have sex with men (GBM) globally including GBM with human immunodeficiency virus (HIV) and HIV-negative GBM, particularly those using HIV preexposure prophylaxis (PrEP). In Australia, HCV direct-acting antiviral treatment (DAA) was government-funded from 2016. Large implementation studies of PrEP also began in 2016. We examined HCV incidence among GBM to assess whether HCV incidence has changed since 2015.
Remdesivir and Mortality in Patients With Coronavirus Disease 2019
George A Diaz, Alyssa B Christensen, Tobias Pusch, Delaney Goulet, Shu-Ching Chang, Gary L Grunkemeier, Paul A McKelvey, Ari Robicsek, Tom French, Guilford T Parsons, Glenn Doherty, Charles Laurenson, Ryan Roper, Jennifer Hadlock, Cameron J Cover, Brent Footer, Philip Robinson, Mary Micikas, Jennifer E Marfori, Charlotte Cronenweth, Yogavedya Mukkamala, Jamie Mackiewicz, Ekra Rai, Martha Dickinson Matson, Jodie Davila, Justin Rueda, Reda Tipton, Heather Algren, Brittney C Ward, Stephen Malkoski, Tyler Gluckman, Gregory B Tallman, Henry Arguinchona, Terese C Hammond, Steven Standaert, Joshua Christensen, Jose F Echaiz, Robert Choi, Daniel McClung, Albert Pacifico, Martin Fee, Farjad Sarafian, William R Berrington, Jason D Goldman
doi : 10.1093/cid/ciab698
Clinical Infectious Diseases, Volume 74, Issue 10, 15 May 2022, Pages 1812–1820
The impact of remdesivir (RDV) on mortality rates in coronavirus disease 2019 (COVID-19) is controversial, and the mortality effect in subgroups of baseline disease severity has been incompletely explored. The purpose of this study was to assess the association of RDV with mortality rates in patients with COVID-19.
Pathology and Pathogenesis of Lassa Fever: Novel Immunohistochemical Findings in Fatal Cases and Clinico-pathologic Correlation
Wun-Ju Shieh, Austin Demby, Tara Jones, Cynthia S Goldsmith, Pierre E Rollin, Thomas G Ksiazek, Clarence J Peters, Sherif R Zaki
doi : 10.1093/cid/ciab719
Clinical Infectious Diseases, Volume 74, Issue 10, 15 May 2022, Pages 1821–1830
Lassa fever is a zoonotic, acute viral illness first identified in Nigeria in 1969. An estimate shows that the “at risk� seronegative population (in Sierra Leone, Guinea, and Nigeria) may be as high as 59 million, with an annual incidence of all illnesses of 3 million, and fatalities up to 67 000, demonstrating the serious impact of the disease on the region and global health.
Efficacy of Cipargamin (KAE609) in a Randomized, Phase II Dose-Escalation Study in Adults in Sub-Saharan Africa With Uncomplicated Plasmodium falciparum Malaria
Esther K Schmitt, Gilles Ndayisaba, Adoke Yeka, Kwaku Poku Asante, Martin P Grobusch, Etienne Karita, Henry Mugerwa, Stephen Asiimwe, Abraham Oduro, Bakary Fofana, Seydou Doumbia, Guoqin Su, Katalin Csermak Renner, Vinay Kumar Venishetty, Sarfaraz Sayyed, Judith Straimer, Ivan Demin, Sarita Barsainya, Caroline Boulton, Preetam Gandhi
doi : 10.1093/cid/ciab716
Clinical Infectious Diseases, Volume 74, Issue 10, 15 May 2022, Pages 1831–1839,
Cipargamin (KAE609) is a potent antimalarial in a phase II trial. Here we report efficacy, pharmacokinetics, and resistance marker analysis across a range of cipargamin doses. These were secondary endpoints from a study primarily conducted to assess the hepatic safety of cipargamin (hepatic safety data are reported elsewhere).
A Longitudinal, Observational Study of Etiology and Long-Term Outcomes of Sepsis in Malawi Revealing the Key Role of Disseminated Tuberculosis
Joseph M Lewis, Madlitso Mphasa, Lucy Keyala, Rachel Banda, Emma L Smith, Jackie Duggan, Tim Brooks, Matthew Catton, Jane Mallewa, Grace Katha, Stephen B Gordon, Brian Faragher, Melita A Gordon, Jamie Rylance, Nicholas A Feasey
doi : 10.1093/cid/ciab710
Clinical Infectious Diseases, Volume 74, Issue 10, 15 May 2022, Pages 1840–1849
Sepsis protocols in sub-Saharan Africa are typically extrapolated from high-income settings, yet sepsis in sub-Saharan Africa is likely caused by distinct pathogens and may require novel treatment strategies. Data to guide such strategies are lacking. We aimed to define causes and modifiable factors associated with sepsis outcomes in Blantyre, Malawi, in order to inform the design of treatment strategies tailored to sub-Saharan Africa.
Accuracy of a Rapid Multiplex Polymerase Chain Reaction Plus a Chromogenic Phenotypic Test Algorithm for Detection of Extended-Spectrum β-Lactamase and Carbapenemase-Producing Gram-Negative Bacilli in Positive Blood Culture Bottles
Sean Wei Xiang Ong, Pei Yun Hon, Sharon Syn Hui Wee, Jonathan Wei Zhong Chia, Shehara Mendis, Ezlyn Izharuddin, Ray Junhao Lin, Po Ying Chia, Rees Chin Swee Sim, Mark I-Cheng Chen, Angela Chow, Joanne Yoong, David Chien Lye, Christine B Teng, Paul Anantharajah Tambyah, Ritu Banerjee, Robin Patel, Partha Pratim De, Shawn Vasoo
doi : 10.1093/cid/ciab848
Clinical Infectious Diseases, Volume 74, Issue 10, 15 May 2022, Pages 1850–1854
We studied the performance of an algorithm combining multiplex polymerase chain reaction with phenotypic detection of extended-spectrum β-lactamases and carbapenemases directly from positive blood culture bottles in patients with gram-negative bacteremia and found good concordance with routine cultures. Such an algorithm may be a tool to improve time to optimal therapy in patients with gram-negative bacteremia.
Total and Unbound Doravirine Concentrations and Viral Suppression in CSF
Juan Tiraboschi, Sofia Scévola, Sujan Dilly Penchala, Elisabeth Challenger, Laura Else, Paula Prieto, Maria Saumoy, Arkaitz Imaz, Ana Silva-Klug, Jordi Niubó, Irene Soriano, Saye Khoo, Raul Rigo-Bonin, Daniel Podzamczer
doi : 10.1093/cid/ciab835
Clinical Infectious Diseases, Volume 74, Issue 10, 15 May 2022, Pages 1855–1858
We determined total and unbound concentrations of doravirine (DOR) in cerebrospinal fluid and blood plasma. Total and unbound DOR concentrations in cerebrospinal fluid exceeded the half-maximal effective concentration against wild-type virus (5.1 ng/mL) in all patients, suggesting that DOR may contribute to inhibit viral replication in this compartment.
Invasive Pneumococcal Disease: Concerning Trends in Serotype 19A Notifications in New Zealand
Andrew Anglemyer, Andrea McNeill, Kara DuBray, Gerard J B . Sonder, Tony Walls
doi : 10.1093/cid/ciab766
Clinical Infectious Diseases, Volume 74, Issue 10, 15 May 2022, Pages 1859–1861
New Zealand (NZ) is one of few countries to shift from PCV13 to PCV10. The number of serotype 19A cases in young children and the proportions of isolates that are penicillin-resistant have been steadily increasing since. It is time for NZ to reconsider its choice of pneumococcal vaccine.
Novel Vector of Scrub Typhus in Sub-Antarctic Chile: Evidence From Human Exposure
Thomas Weitzel, MarÃa Carolina Silva-de la Fuente, Constanza MartÃnez-Valdebenito, Alexandr A Stekolnikov, Caricia Pérez, Ruth Pérez, Cecilia Vial, Katia Abarca, Gerardo Acosta-Jamett
doi : 10.1093/cid/ciab748
Clinical Infectious Diseases, Volume 74, Issue 10, 15 May 2022, Pages 1862–1865
The exposure of a research team to chigger mites in southern Chile allowed the first identification of a trombiculid species as vector and reservoir of scrub typhus outside the tsutsugamushi triangle, providing unique insights into the ecology and transmission of this recently discovered rickettsial infection in South America.
A Nonprofit Drug Development Model Is Part of the Antimicrobial Resistance (AMR) Solution
Laura J V Piddock, Jean-Pierre Paccaud, Seamus O’Brien, Michelle Childs, Rohit Malpani, Manica Balasegaram
doi : 10.1093/cid/ciab887
Clinical Infectious Diseases, Volume 74, Issue 10, 15 May 2022, Pages 1866–1871
Antibiotics underpin modern medicine and are critical for pandemic preparedness. Push funding has revitalized the preclinical antimicrobial resistance (AMR) pipeline and government funding via CARB-X and BARDA, as well as private sector–led investment via the AMR Action Fund, will help several new antibiotics obtain regulatory approval.
Contributions of Animal Studies to the Understanding of Infectious Diseases
Daniel M Musher, Reuben J Arasaratnam
doi : 10.1093/cid/ciab844
Clinical Infectious Diseases, Volume 74, Issue 10, 15 May 2022, Pages 1872–1878
Experiments in animals have played an integral role in furthering basic understanding of the pathophysiology, host immune response, diagnosis, and treatment of infectious diseases.
A 58-Year-old Man With Multifocal Pulmonary Nodules
Mitchell McClean, Samir K Gupta, Ryan F Relich
doi : 10.1093/cid/ciab734
Clinical Infectious Diseases, Volume 74, Issue 10, 15 May 2022, Pages 1879–1882
One in Every 3 Coronavirus Disease 2019 (COVID-19) Reinfections Result in Hospitalization in the United States
Rafael H Bastos, Pedro K Blos, Valeria D Rodrigues, Bruna da S Miranda, Alessandro C Pasqualotto
doi : 10.1093/cid/ciab363
Clinical Infectious Diseases, Volume 74, Issue 10, 15 May 2022, Page 1883
Selective Outcome Reporting in a Randomized Controlled Trial
Emi Kataoka
doi : 10.1093/cid/ciab889
Clinical Infectious Diseases, Volume 74, Issue 10, 15 May 2022, Pages 1883–1884
Reply to Kataoka
Vu Quoc Dat, Ronald B Geskus, Dong Huu Khanh Trinh, Behzad Nadjm, H Rogier van Doorn, Catherine Louise Thwaites
doi : 10.1093/cid/ciab891
Clinical Infectious Diseases, Volume 74, Issue 10, 15 May 2022, Pages 1884–1885
Remarks on the Universal Lifelong Coccidioidomycosis Prophylaxis in Lung Transplant Recipients
Mohanad M Al-Obaidi, Saman Nematollahi, David E Nix, Tirdad T Zangeneh
doi : 10.1093/cid/ciab878
Clinical Infectious Diseases, Volume 74, Issue 10, 15 May 2022, Pages 1885–1886
Reply to Al Obaidi et al
Clover N Truong, Michael D Nailor, Rajat Walia, Lauren Cherrier, Aasya Nasar, Kellie J Goodlet
doi : 10.1093/cid/ciab879
Clinical Infectious Diseases, Volume 74, Issue 10, 15 May 2022, Pages 1886–1887
Syphilis-Naive Patients Achieve Treatment Success More Quickly: A Comparison of Time to Syphilis Treatment Success in Patients With Repeat Versus Naive Infection
Kelika A Konda, Noah Kojima, Silver K Vargas, Gino M Calvo, Michael Reyes-DÃaz, Lorenzo Giacani, Carlos F Cáceres, Jeffrey D Klausner
doi : 10.1093/cid/ciab877
Clinical Infectious Diseases, Volume 74, Issue 10, 15 May 2022, Pages 1887–1888
Correction to: Improved Survival Among Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Treated With Remdesivir and Dexamethasone. A Nationwide Population-Based Cohort Study
Thomas Benfield, Jacob Bodilsen, Christian Brieghel, Zitta Barrella Harboe, Marie Helleberg, Claire Holm, Simone Bastrup Israelsen, Janne Jensen, Tomas Østergaard Jensen, Isik Somuncu Johansen, Stine Johnsen, Birgitte Lindegaard Madsen, Jens Lundgren, Christian Niels Meyer, Rajesh Mohey, Lars Pedersen, Henrik Nielsen, Stig Lønberg Nielsen, Niels Obel, Lars Haukali Omland, Daria Podlekareva, Birgitte Klindt Poulsen, Pernille Ravn, Haakon Sandholdt, Jonathan Starling, Merete Storgaard, Christian Søborg, Ole Schmeltz Søgaard, Torben Tranborg, Lothar Wiese, Hanne Rolighed Christensen
doi : 10.1093/cid/ciac243
Clinical Infectious Diseases, Volume 74, Issue 10, 15 May 2022, Page 1889
Correction to: Increased Peripheral Blood Neutrophil Activation Phenotypes and Neutrophil Extracellular Trap Formation in Critically Ill Coronavirus Disease 2019 Patients: A Case Series and Review of the Literature
Jorge A Masso-Silva, Alexander Moshensky, Michael T Y Lam, Mazen Odish, Arjun Patel, Le Xu, Emily Hansen, Samantha Trescott, Celina Nguyen, Roy Kim, Katherine Perofsky, Samantha Perera, Lauren Ma, Josephine Pham, Mark Rolfsen, Jarod Olay, John Shin, Jennifer M Dan, Robert Abbott, Sydney Ramirez, Thomas H Alexander, Grace Y Lin, Ana Lucia Fuentes, Ira Advani, Deepti Gunge, Victor Pretorius, Atul Malhotra, Xin Sun, Jason Duran, Mark Hepokoski, Shane Crotty, Nicole G Coufal, Angela Meier, Laura E Crotty Alexander
doi : 10.1093/cid/ciac216
Clinical Infectious Diseases, Volume 74, Issue 10, 15 May 2022, Pages 1889–1890
Correction to: If, When, and How to Use Rifampin in Acute Staphylococcal Periprosthetic Joint Infections, a Multicentre Observational Study
Mark Beldman, Claudia Löwik, Alex Soriano, Laila Albiach, Wierd P Zijlstra, Bas A S Knobben, Paul Jutte, Ricardo Sousa, André Carvalho, Karan Goswami, Javad Parvizi, Katherine A Belden, Marjan Wouthuyzen-Bakker
doi : 10.1093/cid/ciac149
Clinical Infectious Diseases, Volume 74, Issue 10, 15 May 2022, Page 1890
Corrigendum to: Guidance for Systematic Integration of Undernutrition in Attributing Cause of Death in Children
Christina R Paganelli, Nicholas Kassebaum, Kathleen Strong, Parminder S Suchdev, Wieger Voskuijl, Quique Bassat, Dianna M Blau, Donna M Denno
doi : 10.1093/cid/ciac084
Clinical Infectious Diseases, Volume 74, Issue 10, 15 May 2022, Page 1891
Correction to: Reply to van Deun and Decroo
J P Peter Cegielski, Zarir F Udwadia, Piret Viiklepp, Jae-Joon Yim, Dick Menzies
doi : 10.1093/cid/ciac241
Clinical Infectious Diseases, Volume 74, Issue 10, 15 May 2022, Page 1891
Correction to: The Natural History of Anal High-grade Squamous Intraepithelial Lesions in Gay and Bisexual Men
I Mary Poynten, Fengyi Jin, Jennifer M Roberts, David J Templeton, Carmella Law, Alyssa M Cornall, Monica Molano, Dorothy A Machalek, Andrew Carr, Annabelle Farnsworth, Sepehr Tabrizi, Samuel Phillips, Christopher K Fairley, Suzanne M Garland, Richard J Hillman, Andrew E Grulich
doi : 10.1093/cid/ciac150
Clinical Infectious Diseases, Volume 74, Issue 10, 15 May 2022, Page 1892
Correction to: Epidemiology and Outcome of Fungemia in a Cancer Cohort of the Infectious Diseases Group (IDG) of the European Organization for Research and Treatment of Cancer (EORTC 65031)
Oliver A Cornely, Bertrand Gachot, Hamdi Akan, Matteo Bassetti, Omrun Uzun, Christopher Kibbler, Oscar Marchetti, Peter de Burghgraeve, Safaa Ramadan, Liisa Pylkkanen, Lieveke Ameye, Marianne Paesmans, J Peter Donnelly
doi : 10.1093/cid/ciac144
Clinical Infectious Diseases, Volume 74, Issue 10, 15 May 2022, Page 1892
Erratum to: Primary Care Guidance for Persons With Human Immunodeficiency Virus: 2020 Update by the HIV Medicine Association of the Infectious Diseases Society of America
Melanie A Thompson, Michael A Horberg, Allison L Agwu, Jonathan A Colasanti, Mamta K Jain, William R Short, Tulika Singh, Judith A Aberg
doi : 10.1093/cid/ciab801
Clinical Infectious Diseases, Volume 74, Issue 10, 15 May 2022, Pages 1893–1898
Digital Strategy and Social Media for Infectious Diseases
Jasmine R Marcelin, Carlos del Rio, Andrej Spec, Talia H Swartz
doi : 10.1093/cid/ciac046
Clinical Infectious Diseases, Volume 74, Issue Supplement_3, 15 May 2022, Pages S219–S221
This supplement demonstrates the profound reach of social media across several domains: improved clinical care and advocacy, data analysis, broad reach to diverse patient populations, educational access, best practices in medical education, peer review, digital strategy for individuals and institutions, and combating misinformation.
Social Media: Flattening Hierarchies for Women and Black, Indigenous, People Of Color (BIPOC) to Enter the Room Where It Happens
Boghuma K Titanji, Jacinda C Abdul-Mutakabbir, Briana Christophers, Laura Flores, Jasmine R Marcelin, Talia H Swartz
doi : 10.1093/cid/ciac047
Clinical Infectious Diseases, Volume 74, Issue Supplement_3, 15 May 2022, Pages S222–S228
Social media platforms are widely used to connect people across multiple settings, including country of origin, profession, race/ethnicity, sexual orientation, gender identity, seniority, and training. Groups that have been marginalized or historically excluded from decision-making encounters may lack formal mentors/sponsors because of a lack of representation of women and Black, Indigenous, People Of Color (BIPOC) in senior leadership positions. This can serve as a barrier to professional advancement at all stages of career development.
#SoMe the Money! Value, Strategy, and Implementation of Social Media Engagement for Infectious Diseases Trainees, Clinicians, and Divisions
Kelly A Cawcutt, Jasmine R Marcelin, Nicolás Cortés-Penfield, James B Cutrell, Sara W Dong, Monica V Mahoney, Todd P McCarty, Krutika Mediwala Hornback, Boghuma K Titanji, Laila E Woc-Colburn, Ilan S Schwartz
doi : 10.1093/cid/ciac063
Clinical Infectious Diseases, Volume 74, Issue Supplement_3, 15 May 2022, Pages S229–S236
Social media platforms have revolutionized how we consume information, along with how to effectively present communication, education, and advocacy efforts. There is profound value in leveraging social media within these aspects for the field of infectious diseases, for divisions and individual clinicians. Herein, we provide the rationale to incorporate social media as a key competency for infectious diseases training and specific guidance on aspects of education and strategic development of new accounts critical for success.
The Digital Classroom: How to Leverage Social Media for Infectious Diseases Education
Saman Nematollahi, Daniel J Minter, Brooke Barlow, Nathanial S Nolan, Jennifer O Spicer, Darcy Wooten, Nicolas Cortes-Penfield, Ashley Barlow, Miguel A Chavez, Todd McCarty, Emily Abdoler, Gerome V Escota
doi : 10.1093/cid/ciac048
Clinical Infectious Diseases, Volume 74, Issue Supplement_3, 15 May 2022, Pages S237–S243
Social media (SoMe) platforms have been increasingly used by infectious diseases (ID) learners and educators in recent years. This trend has only accelerated with the changes brought to our educational spaces by the coronavirus disease 2019 pandemic.
Educational Impact of #IDJClub, a Twitter-Based Infectious Diseases Journal Club
Ilan S Schwartz, Todd McCarty, Laila E Woc-Colburn, Boghuma K Titanji, James B Cutrell, Nicolas W Cortes-Penfield
doi : 10.1093/cid/ciac108
Clinical Infectious Diseases, Volume 74, Issue Supplement_3, 15 May 2022, Pages S244–S250
Journal clubs have been an enduring mainstay of medical education, and hosting these on social media platforms can expand accessibility and engagement. We describe the creation and impact of #IDJClub, an infectious diseases (ID) Twitter journal club.
Surgeons, Infectious Diseases, and Twitter Hit a Home Run for Antibiotic Stewardship
Debra A Goff, John Alverdy, Anthony T Gerlach, Julio Mayol, Benedict Nwomeh
doi : 10.1093/cid/ciac049
Clinical Infectious Diseases, Volume 74, Issue Supplement_3, 15 May 2022, Pages S251–S256
Many infectious diseases (ID) clinicians join Twitter to follow other ID colleagues or “like� people. While there is great value in engaging with people who have similar interests, there is equal value in engaging with “unlike� or non-ID people.
Population Mobility and Aging Accelerate the Transmission of Coronavirus Disease 2019 in the Deep South: A County-Level Longitudinal Analysis
Chengbo Zeng, Jiajia Zhang, Zhenlong Li, Xiaowen Sun, Xueying Yang, Bankole Olatosi, Sharon Weissman, Xiaoming Li
doi : 10.1093/cid/ciac050
Clinical Infectious Diseases, Volume 74, Issue Supplement_3, 15 May 2022, Pages e1–e3
Population mobility and aging at local areas contributed to the geospatial disparities in the coronavirus disease 2019 (COVID-19) transmission among 418 counties in the Deep South. In predicting the incidence of COVID-19, a significant interaction was found between mobility and the proportion of older adults. Effective disease control measures should be tailored to vulnerable communities.
Exploring Coronavirus Disease 2019 Vaccine Hesitancy on Twitter Using Sentiment Analysis and Natural Language Processing Algorithms
Anasse Bari, Matthias Heymann, Ryan J Cohen, Robin Zhao, Levente Szabo, Shailesh Apas Vasandani, Aashish Khubchandani, Madeline DiLorenzo, Megan Coffee
doi : 10.1093/cid/ciac141
Clinical Infectious Diseases, Volume 74, Issue Supplement_3, 15 May 2022, Pages e4–e9
Vaccination can help control the coronavirus disease 2019 (COVID-19) pandemic but is undermined by vaccine hesitancy. Social media disseminates information and misinformation regarding vaccination. Tracking and analyzing social media vaccine sentiment could better prepare health professionals for vaccination conversations and campaigns.
Go V.I.R.A.L.: Social Media Engagement Strategies in Infectious Diseases
Bradley J Langford, Maryrose Laguio-Vila, Timothy P Gauthier, Aditya Shah
doi : 10.1093/cid/ciac051
Clinical Infectious Diseases, Volume 74, Issue Supplement_3, 15 May 2022, Pages e10–e13
Social media has emerged as a tool to facilitate communication and dissemination of information for both patients and healthcare professionals. We describe 3 social media engagement strategies used to reach a broad and diverse audience on the topics of infectious diseases and antimicrobial stewardship, including the use of memes, a clue-based knowledge assessment quiz, and a personality quiz.
Creating Effective Infographics and Visual Abstracts to Disseminate Research and Facilitate Medical Education on Social Media
Jennifer O Spicer, Caroline G Coleman
doi : 10.1093/cid/ciac058
Clinical Infectious Diseases, Volume 74, Issue Supplement_3, 15 May 2022, Pages e14–e22
Presenting information in a visual format helps viewers digest complex concepts in an efficient, effective manner. Recently, infographics have been used on social media and other digital platforms to educate health professionals, trainees, and patients about medical and public health topics.
How to Harness the Power of Social Media for Quality Drug Information in Infectious Diseases: Perspectives on Behalf of the Society of Infectious Diseases Pharmacists
Kelli A Cole, Anna Y Zhou, Travis Jones, W Justin Moore, Elisabeth L Chandler, Veronica B Zafonte, Taylor Morrisette, Timothy P Gauthier, Jamie Kisgen, Amanda Barner, Melissa D Johnson, R Dawn Tagare, Julie Ann Justo
doi : 10.1093/cid/ciac081
Clinical Infectious Diseases, Volume 74, Issue Supplement_3, 15 May 2022, Pages e23–e33
Clinicians, researchers, and the public frequently turn to digital channels and social media for up-to-the-minute information on novel therapeutics and vaccines. The value of credible infectious diseases drug information is more apparent in the setting of the coronavirus disease 2019 (COVID-19) pandemic.
Misinformation and Disinformation: The Potential Disadvantages of Social Media in Infectious Disease and How to Combat Them
Angel N Desai, Diandra Ruidera, Julie M Steinbrink, Bruno Granwehr, Dong Heun Lee
doi : 10.1093/cid/ciac109
Clinical Infectious Diseases, Volume 74, Issue Supplement_3, 15 May 2022, Pages e34–e39
Although the use of social media to spread misinformation and disinformation is not a new concept, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has further highlighted the dangers that misinformation can pose to public health.
